Clinical Trial Update: A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tinea Pedis [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating safety and efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel for tinea pedis is in progress with status unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tinea Pedis

Drugs mentioned

• Aqueous Gel (Aqueous Gel)
• DBI-001 Gel (DBI-001 Gel)
• DBI-002 Gel (DBI-002 Gel)

Snippet

Sponsor: DermBiont, Inc. | Conditions: Tinea Pedis | Phase 2 | Status: UNKNOWN